510(k) K182157
K182157 is an FDA 510(k) premarket notification submitted by Princeton BioMeditech Corp. for the device "BioSign Flu A+B". The FDA issued a decision of Substantially Equivalent on Sep 18, 2018. The device falls under product code PSZ (Devices Detecting Influenza A, B, And C Virus Antigens), a Class II device regulated under 21 CFR 866.3328. Princeton BioMeditech Corp. has 71 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 18, 2018
- Date Received
- Aug 9, 2018
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Devices Detecting Influenza A, B, And C Virus Antigens
- Device Class
- Class II
- Regulation Number
- 866.3328
- Review Panel
- MI
- Submission Type
- 510(k)
An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.
Need the full FDA record for Princeton BioMeditech Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.